ARTV
Artiva Biotherapeutics, Inc.
7.70$
-4.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -764.4% | -1,030.8% | -141.6% | -21,925.1% | – | |
| – | 12.4% | 23.5% | 6.8% | 968.5% | – | |
| – | 215.1% | 133.5% | 21.1% | 2,780.9% | – | |
| – | 1,669.0% | -78.4% | -84.4% | -129.5% | – | |
| – | 86.1% | 127.7% | 9.7% | 255.8% | – | |
| – | -86.1% | -127.7% | -77.6% | -47,993.2% | – | |
| – | – | -0.1% | 0.0% | -1,666.5% | – | |
| – | 0.0% | – | 0.0% | -59.4% | – | |
| – | 7,630.1% | -25.6% | 72.8% | 64,631.9% | – | |
| – | 6,779.5% | -1,184.2% | -146.3% | -5,286.5% | – | |
| – | -850.5% | -1,158.5% | -151.3% | -22,180.9% | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.